Production (Stage)
Lipella Pharmaceuticals Inc.
LIPO
$2.99
-$0.10-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.68% | -33.66% | -43.83% | -61.89% | -47.61% |
| Total Receivables | 24.24% | 162.23% | -41.43% | 26.07% | -17.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -38.74% | 236.59% | 234.07% | 281.27% | 122.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 60.18% | -23.68% | -22.13% | -38.20% | -32.76% |
|
|
|||||
| Total Current Assets | 60.18% | -23.68% | -22.13% | -38.20% | -32.76% |
| Net Property, Plant & Equipment | -74.07% | -61.73% | -52.85% | -15.67% | -7.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 54.79% | -25.25% | -23.96% | -37.41% | -32.02% |
|
|
|||||
| Total Accounts Payable | 33.46% | 181.30% | 51.60% | 707.24% | 97.31% |
| Total Accrued Expenses | 116.90% | 101.52% | 7.89% | -3.56% | -35.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -73.83% | -46.64% | -18.90% | 54.11% | 54.12% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 40.75% | 95.74% | 27.79% | 60.74% | -23.07% |
|
|
|||||
| Total Current Liabilities | 40.75% | 95.74% | 27.79% | 60.74% | -23.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -70.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.88% | 74.35% | 13.24% | 31.88% | -27.87% |
|
|
|||||
| Common Stock & APIC | 47.23% | 28.15% | 29.53% | 23.79% | 32.94% |
| Retained Earnings | -44.56% | -48.59% | -44.25% | -49.84% | -70.03% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 59.26% | -38.96% | -34.33% | -45.48% | -32.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.26% | -38.96% | -34.33% | -45.48% | -32.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.26% | -38.95% | -34.33% | -45.48% | -32.89% |
|
|
|||||